ChK1 inhibitor (BioFocus/Avantogen)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameChK1 inhibitor (BioFocus/Avantogen)
Drug Alias Nameanticancer therapeutics (BioFocus/Avantogen)anticancer therapeutics (BioFocus/AustCancer)Chk1 inhibitor (BioFocus/AustCancer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 1 inhibitors
TargetsCheckpoint kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioFocus DPI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioFocus DPIAcuvax
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A